Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Post by Walterthedogon Sep 22, 2020 11:09am
117 Views
Post# 31597216

Market share

Market shareWe have been in the business of weed for about 6 years and we currently have about .001% of the total sales of cannabis in Canada. It has been 2 years since rec opened and we have sales of about 1M$ per quarter. Granted we have done this on a budget that allows us to pay the bills which is a great achievement. That being said I don't know why any of us thought that we would be able to capture a significant portion of the drink market with the same team in place. Will it take 2 years to get 2.0 product sales up to 1M$? And if so what chance do we have to actually build sales and value in the company? I'm gonna call Miller today and try and dig him for some answers. He is really good at telling me things I wanna hear so its kinda pointless but maybe i can get some info. It seems like the problems plaguing our early dry sales with production and shipping are playing out again with KISS and maybe increasing competition and a market for beverages still in its infancy are factors but a company presentation with some goals etc would sure go a long way with investors. I've kind of lost my last shred of hope here and Im seriously starting to doubt we will ever see .23$ again.
<< Previous
Bullboard Posts
Next >>